SEARCH

SEARCH BY CITATION

References

  • 1
    Noseworthy, J. H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B. G., Multiple sclerosis. N. Engl. J. Med. 2000. 343: 938952.
  • 2
    Reichardt, H. M., Gold, R. and Lühder, F., Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Expert Rev. Neurother. 2006. 6: 16571670.
  • 3
    Tischner, D. and Reichardt, H. M., Glucocorticoids in the control of neuroinflammation. Mol. Cell. Endocrinol. 2007. 275: 6270.
  • 4
    Gold, R., Giegerich, G., Hartung, H. P. and Toyka, K. V., T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 82-positive T cells are not essential for induction and course of disease. Proc. Natl. Acad. Sci. USA 1995. 92: 58505854.
  • 5
    Flügel, A., Willem, M., Berkowicz, T. and Wekerle, H., Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat. Med. 1999. 5: 843847.
  • 6
    Flügel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D. E., Li, Z., Ellwart, J. W. et al., Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001. 14: 547560.
  • 7
    Glaser, S., Anastassiadis, K. and Stewart, A. F., Current issues in mouse genome engineering. Nat. Genet. 2005. 37: 11871193.
  • 8
    Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E. and Mello, C. C., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998. 391: 806811.
  • 9
    Sontheimer, E. J. and Carthew, R. W., Silence from within: endogenous siRNAs and miRNAs. Cell 2005. 122: 912.
  • 10
    Herold, M. J., van den Brandt, J., Seibler, J. and Reichardt, H. M., Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl. Acad. Sci. USA 2008. 105: 1850718512.
  • 11
    Lim, H. Y., van den Brandt, J., Fassnacht, M., Allolio, B., Herold, M. J. and Reichardt, H. M., Silencing of the mineralocorticoid receptor by ribonucleic acid interference in transgenic rats disrupts endocrine homeostasis. Mol. Endocrinol. 2008. 22: 13041311.
  • 12
    Pozzilli, C., Marinelli, F., Romano, S. and Bagnato, F., Corticosteroids treatment. J. Neurol. Sci. 2004. 223: 4751.
  • 13
    Migita, K., Eguchi, K., Kawabe, Y., Nakamura, T., Shirabe, S., Tsukada, T., Ichinose, Y. et al., Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy. Transplantation 1997. 63: 583587.
  • 14
    Schmidt, J., Gold, R., Schonrock, L., Zettl, U. K., Hartung, H. P. and Toyka, K. V., T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 2000. 123: 14311441.
  • 15
    Almawi, W. Y., Beyhum, H. N., Rahme, A. A. and Rieder, M. J., Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 1996. 60: 563572.
  • 16
    Correale, J., Arias, M. and Gilmore, W., Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 1998. 161: 33653374.
  • 17
    Chen, X., Oppenheim, J. J., Winkler-Pickett, R. T., Ortaldo, J. R. and Howard, O. M., Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 2006. 36: 21392149.
  • 18
    Elovaara, I., Lalla, M., Spare, E., Lehtimaki, T. and Dastidar, P., Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS. Neurology 1998. 51: 17031708.
  • 19
    Gelati, M., Corsini, E., Dufour, A., Massa, G., Giombini, S., Solero, C. L. and Salmaggi, A., High-dose methylprednisolone reduces cytokine-induced adhesion molecules on human brain endothelium. Can. J. Neurol. Sci. 2000. 27: 241244.
  • 20
    Engelhardt, B., Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural. Transm. 2006. 113: 477485.
  • 21
    Paul, C. and Bolton, C., Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int. J. Immunopharmacol. 1995. 17: 497503.
  • 22
    Wüst, S., van den Brandt, J., Tischner, D., Kleiman, A., Tuckermann, J. P., Gold, R., Lühder, F. and Reichardt, H. M., Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J. Immunol. 2008. 180: 84348443.
  • 23
    Tuckermann, J. P., Kleiman, A., McPherson, K. G. and Reichardt, H. M., Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 2005. 42: 71104.
  • 24
    Herold, M. J., McPherson, K. G. and Reichardt, H. M., Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 2006. 63: 6072.
  • 25
    Franchimont, D., Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann. NY Acad. Sci. 2004. 1024: 124137.
  • 26
    Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K. P., Hanisch, U. K., Raasch, J., Merkler, D. et al., Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008. 28: 675686.
  • 27
    Gutcher, I., Urich, E., Wolter, K., Prinz, M. and Becher, B., Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat. Immunol. 2006. 7: 946953.
  • 28
    Gold, R., Linington, C. and Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006. 129: 19531971.
  • 29
    Hamasaki, A., Sendo, F., Nakayama, K., Ishida, N., Negishi, I., Nakayama, K. and Hatakeyama, S., Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J. Exp. Med. 1998. 188: 19851992.
  • 30
    Oberdoerffer, P., Kanellopoulou, C., Heissmeyer, V., Paeper, C., Borowski, C., Aifantis, I., Rao, A. and Rajewsky, K., Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages. Mol. Cell. Biol. 2005. 25: 38963905.
  • 31
    Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P. et al., Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006. 441: 537541.
  • 32
    Scacheri, P. C., Rozenblatt-Rosen, O., Caplen, N. J., Wolfsberg, T. G., Umayam, L., Lee, J. C., Hughes, C. M. et al., Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 2004. 101: 18921897.
  • 33
    Goffinet, C. and Keppler, O. T., Efficient nonviral gene delivery into primary lymphocytes from rats and mice. FASEB J. 2006. 20: 500502.
  • 34
    McManus, M. T., Haines, B. B., Dillon, C. P., Whitehurst, C. E., van Parijs, L., Chen, J. and Sharp, P. A., Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 2002. 169: 57545760.
  • 35
    Schiffelers, R. M., Xu, J., Storm, G., Woodle, M. C. and Scaria, P. V., Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum. 2005. 52: 13141318.
  • 36
    Scherr, M., Battmer, K., Dallmann, I., Ganser, A. and Eder, M., Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation model. Oligonucleotides 2003. 13: 353363.
  • 37
    Lovett-Racke, A. E., Rocchini, A. E., Choy, J., Northrop, S. C., Hussain, R. Z., Ratts, R. B., Sikder, D. and Racke, M. K., Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 2004. 21: 719731.
  • 38
    Fontoura, P., Steinman, L. and Miller, A., Emerging therapeutic targets in multiple sclerosis. Curr. Opin. Neurol. 2006. 19: 260266.
  • 39
    Leussink, V. I., Jung, S., Merschdorf, U., Toyka, K. V. and Gold, R., High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch. Neurol. 2001. 58: 9197.
  • 40
    Jung, S., Toyka, K. and Hartung, H. P., Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Eur. J. Immunol. 1995. 25: 13911398.
  • 41
    Eylar, E. H., Kniskern, P. J. and Jackson, J. J., Myelin basic proteins. Methods Enzymol. 1974. 32: 323341.
  • 42
    Schmidt, J., Metselaar, J. M., Wauben, M. H., Toyka, K. V., Storm, G. and Gold, R., Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 2003. 126: 18951904.
  • 43
    Tischner, D., Weishaupt, A., van den Brandt, J., Müller, N., Beyersdorf, N., Ip, C. W., Toyka, K. V. et al., Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain 2006. 129: 26352647.
  • 44
    van den Brandt, J., Voss, K., Schott, M., Hünig, T., Wolfe, M. S. and Reichardt, H. M., Inhibition of Notch signaling biases rat thymocyte development towards the NK cell lineage. Eur. J. Immunol. 2004. 34: 14051413.
  • 45
    Zettl, U. K., Gold, R., Toyka, K. V. and Hartung, H. P., Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat. J. Neuropathol. Exp. Neurol. 1995. 54: 540547.